Close
13/12/2017
ALBA Synchrotron Works for People’s Health
Two recent works remind us that ALBA synchrotron is a very valuable tool to help develop new drugs.

On one hand, using the MIRAS beam line of the ALBA synchrotron (infrared radiations), researchers from the Universitat Autònoma de Barcelona (UAB) and the ALBA Synchrotron have demonstrated in a paper the capability of metalosomes - aggregates made of phospholipids and metal complexes - to interact with cells and release carbon monoxide in a controlled way (CO release can be beneficial because of its anti-inflammatory, vasodilator and cardio protective properties).
 
On the other hand, in another publication, a team led by researchers from the Universitat Politècnica de Catalunya (UPC) has unveiled the mechanism of action of two drugs, FR60 and JNI18, which cure 100% of mice with sleeping sickness. Using X-rays of the ALBA XALOC beam line, they have observed how these drugs perfectly stacked on the Trypanosoma brucei’s DNA, the parasite that causes the disease (image). Blocking and inflicting specific damage on its DNA, the parasite cannot reproduce and finally dies after 4-5 days.
 

More news

31/01/2015 Iranian entrepreneurs at the ALBA synchrotron 22/01/2015 What is a synchrotron and how it works? 15/01/2015 AFM2015 at ICMAB: Nanoscale Characterization of Functional Materials 08/01/2015 Ice under investigation: ICN2 and ICMAB sign an agreement with SnowWorld 23/12/2014 Kymos Pharma Services in the PTV 18/12/2014 Barcelona is one of the 20 best cities for students
35 36 37 38 39 40 41 42 43 44 45